Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Jul 1;108(7):1718-1720.
doi: 10.3324/haematol.2022.282441.

Second chances - better than none

Jane Liesveld  1
Affiliations
Editorial

Second chances - better than none

Jane Liesveld. Haematologica. .
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Disposition of the 407 patients who relapsed afer hematopoietic stem cell transplant in the study by Yerushalmi et al. AML: acute myelogenous leukemia; MDS: myelodysplastic syndrome; HSCT2: second hematopoietic stem cell transplant; OS: overall survival; GvHD: graft-versus-host disease; URD: unrelated donor.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Yerushalmi Y, Shem-Tov N, Danylesko I, et al. . Second hematopoietic stem cell transplantation as salvage therapy for relapsed acute myeloid leukemia/myelodysplastic syndromes after a first transplantation. Haematologica. 2023;108(7):1782-1792. - PMC - PubMed
    1. Zuanelli Brambilla C, Lobaugh SM, Ruiz JD, et al. . Relapse after allogeneic stem cell transplantation of acute myelogenous leukemia and myelodysplastic syndrome and the importance of second cellular therapy. Transplant Cell Ther. 2021;27(9):771. - PMC - PubMed
    1. Yalniz FF, Saliba RM, Greenbaum U, et al. . Outcomes of second allogeneic hematopoietic cell transplantation for patients with acute myeloid leukemia. Transplant Cell Ther. 2021;27(8):689-695. - PMC - PubMed
    1. Ruutu T, de Wreede LC, van Biezen A, et al. . Second allogeneic transplantation for relapse of malignant disease: retrospective analysis of outcome and predictive factors by the EBMT. Bone Marrow Transplant. 2015;50(12):1542-1550. - PubMed
    1. Kharfan-Dabaja MA, Labopin M, Brissot E, Ket al. Second allogeneic haematopoietic cell transplantation using HLA-matched unrelated versus T-cell replete haploidentical donor and survival in relapsed acute myeloid leukaemia. Br J Haematol. 2021;193(3):592-601. - PubMed

Publication types